Sanofi acquires Dynavax for $2.2B, boosting its vaccine portfolio with HEPLISAV-B and a shingles candidate. Click for my ...

Sanofi acquires Dynavax for $2.2B, gaining Heplisav-B and promising vaccine pipeline. Click here to read my analysis of SNY stock and the DVAX acquisition.

Sanofi to acquire Dynavax, adding a marketed adult hepatitis B vaccine and phase 1/2 shingles candidate to the pipeline Paris, December 24, 2025.

Bob Mortimer is a British comedian, author, podcaster and writer, best known for being one half of iconic comedy duo, ...

Learn how to get the vaccines you need now to protect yourself from illnesses, including flu, RSV, measles, Covid-19, and ...

Sheldon Rankins has returned for a second stint with the Houston Texans after spending the 2024 season with the Cincinnati Bengals. On Monday, Rankins revealed that he dealt with quite a bit of ...

Metal roofs have a lot to offer. Despite the higher up-front cost, a metal roof is likely to be a cost-effective choice in the long run. That’s in no small part because they can last anywhere from 40 ...

Many people think shingles—a viral infection that causes a painful rash—is something only older people deal with, given that the risk generally increases with age. But Jacquelyn Gill, a professor at ...

Older adults may want to seek out the shingles vaccine if they already haven't. Getting vaccinated for the viral illness shingles, which causes a painful rash, could potentially be the next best tool ...

People who receive the live-attenuated shingles vaccine may have a lower likelihood of being diagnosed with dementia compared with those who do not get the shot, researchers report April 2 in Nature.

Getting vaccinated against shingles — a painful and debilitating condition that can flare up years after infection from varicella zoster — not only lowers the risk of developing the rash, but may also ...

LONDON, March 25 (Reuters) - GSK (GSK.L), opens new tab said on Tuesday that it is studying a group of more than a million older adults in the UK to examine whether its best-selling shingles vaccine ...